Visium Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Visium Asset Management’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,471	Closed	-$366K	–	1012
2015 Q3	$366K	Buy	+8,471	New	+$357K	0.01%	642
2015 Q2	–	Sell	-333,244	Closed	-$12.9M	–	1393
2015 Q1	$12.9M	Sell	333,244 -42,500	-11%	-$1.64M	0.19%	108
2014 Q4	$12.7M	Sell	375,744 -60,663	-14%	-$2.14M	0.18%	105
2014 Q3	$15.3M	Sell	436,407 -139,039	-24%	-$4.77M	0.23%	98
2014 Q2	$18.9M	Buy	575,446 +274,694	+91%	+$9.4M	0.29%	59
2014 Q1	$11.1M	Buy	+300,752	New	+$11M	0.18%	109

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Visium Asset Management's WX Position: Q4 2015 in Review

Visium Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 8,471 shares — an estimated $366K sold.

Visium Asset Management first reported a position in WX in Q1 2014 and held it in 6 quarters. The position peaked at $18.9M in Q2 2014. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Visium Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Visium Asset Management sold 8,471 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $366K.
Visium Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 6 quarters.
Visium Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $18.9M in Q2 2014.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.